301 - 325 of 450
Number of results to display per page
TitleDateTypeSetname
301 It Is What it is Until it isn't, GCA Presenting with Orbital Inflammation2023-03-14Textehsl_novel_nam
302 The Localizing Value of the Relative Afferent Pupillary Defect in Patients with Efferent Ocular Disease2019-03ehsl_novel_nam
303 Near-miss of the optic nerve from a deep penetrating orbital injury with a kitchen knife.ehsl_novel_jno
304 Orbital Magnetic ResonanceTextehsl_novel_nam
305 Painless Diplopia as Initial Presentation of Metastatic Lobular Breast Carcinoma2020-03Textehsl_novel_nam
306 Proptosis and Myopathy from Dysthyroid Orbitopathy (Kennerdell Case 47, PPT)Textehsl_novel_jsk
307 The Purple and Ugly Are Hidden Inside2020-03Textehsl_novel_nam
308 Rapidly progressing retinal dystrophy in Spinocerebellar Ataxia 7 (SCA7): A case report of three brothers2019-03ehsl_novel_nam
309 Severe Heavy Eye Syndrome With Esotropia and Hypertropia in a Female With Congenital Monocular Anophthalmia2022-02Textehsl_novel_nam
310 Tendon-sparing Extraocular Muscle Enlargement and Cranial Nerve Hypertrophy in Chronic Inflammatory Demyelinating Polyneuropathy2022-02Textehsl_novel_nam
311 THRIVE: A Phase 3 Trial of VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED)2023-03-14Textehsl_novel_nam
312 Ultramicroscopic study of the Optic Nerve Sheath in Patients with Severe Vision Loss from Idiopathic Intracranial Hypertension- Results2015-02-22Textehsl_novel_nam
313 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients2023-03Textehsl_novel_nam
314 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients2023-03Image/MovingImageehsl_novel_nam
315 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients2023-03Textehsl_novel_nam
316 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor in Development for Thyroid Eye Disease (TED), Binds to a Distinct Epitope from Teprotumumab2023-03-14Textehsl_novel_nam
317 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor in Development for Thyroid Eye Disease (TED): Interim Phase 1/2 Pharmacodynamic Results2023-03-14Textehsl_novel_nam
318 VRDN-002, a Next-Generation Novel Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Results of a Phase 1 Trial2023-03-14Textehsl_novel_nam
319 A Case of MOG Negative Chronic Relapsing Inflammatory Optic Neuropathy (CRION)2023-03-14Textehsl_novel_nam
320 A Case of Multiple Myeloma Relapse Presenting with Proptosis2020-03Textehsl_novel_nam
321 A Case of Thyroid Eye Disease-associated Ischemic Optic Neuropathy2023-03-14Textehsl_novel_nam
322 Embryonal Rhabdomyosarcoma (Kennerdell Case 41, PPT)Textehsl_novel_jsk
323 Horner Syndrome and Internuclear Ophthalmoplegia From Biopsy Proven Giant Cell Arteritis2022-02Textehsl_novel_nam
324 Multiple Myeloma: Epibulbar Plasmacytoma Causing Diplopia2023-03-14Textehsl_novel_nam
325 NANOS Illustrated Curriculum Section A Introduction2024-02ehsl_novel_novel
301 - 325 of 450